Biomarkers are transforming neurological research by enabling earlier diagnosis, monitoring disease progression, and evaluating treatment response. Molecular neuroscience continues to provide valuable insights into the biological mechanisms underlying neurological disorders.
This track focuses on genetic biomarkers, protein biomarkers, neuroimaging markers, cerebrospinal fluid analysis, molecular diagnostics, and precision medicine. Discussions will highlight advances in biomarker discovery and translational neuroscience.
Attendees will learn about innovative diagnostic technologies, personalized therapeutic strategies, and emerging research that is advancing the future of neurological care.